Novo Nordisk A/S (NYSE:NVO) Q4 2025 Earnings Call Transcript February 4, 2026
Novo Nordisk A/S beats earnings expectations. Reported EPS is $1, expectations were $0.9.
Operator: Good day, and thank you for standing by. Welcome to the Q4 2025 Novo Nordisk Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Michael Novod, Head of Investor Relations. Please go...
